New Mexico Educational Retirement Board Regeneron Pharmaceuticals, Inc. Transaction History

New Mexico Educational Retirement Board

  • $2.98 Billion
  • Q4 2024

A detailed history of New Mexico Educational Retirement Board transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New Mexico Educational Retirement Board holds 5,100 shares of REGN stock, worth $3.43 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,100
Previous 5,200 1.92%
Holding current value
$3.43 Million
Previous $5.47 Million 33.53%
% of portfolio
0.12%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
SELL
$701.85 - $1046.91 $70,185 - $104,691
-100 Reduced 1.92%
5,100 $3.63 Million
Q3 2024

Nov 12, 2024
SELL
$1024.09 - $1201.76 $204,817 - $240,352
-200 Reduced 3.7%
5,200 $5.47 Million
Q1 2024

Apr 23, 2024
SELL
$902.69 - $993.35 $722,152 - $794,680
-800 Reduced 12.9%
5,400 $5.2 Million
Q1 2024

Apr 17, 2024
BUY
$902.69 - $993.35 $541,614 - $596,010
600 Added 10.71%
6,200 $4.33 Million
Q3 2023

Nov 01, 2023
BUY
$692.45 - $844.37 $276,980 - $337,748
400 Added 7.69%
5,600 $4.61 Million
Q2 2023

Jul 17, 2023
BUY
$700.03 - $830.35 $140,006 - $166,070
200 Added 4.0%
5,200 $3.74 Million
Q1 2023

May 03, 2023
SELL
$680.49 - $826.97 $68,049 - $82,697
-100 Reduced 1.96%
5,000 $4.11 Million
Q4 2022

Feb 01, 2023
SELL
$705.89 - $766.39 $282,356 - $306,556
-400 Reduced 7.27%
5,100 $3.68 Million
Q3 2022

Oct 18, 2022
SELL
$573.97 - $724.32 $229,588 - $289,728
-400 Reduced 6.78%
5,500 $3.79 Million
Q2 2022

Jul 21, 2022
SELL
$548.35 - $738.84 $164,505 - $221,652
-300 Reduced 4.84%
5,900 $3.49 Million
Q1 2022

Apr 01, 2022
SELL
$595.12 - $698.43 $119,024 - $139,686
-200 Reduced 3.13%
6,200 $4.33 Million
Q4 2021

Jan 19, 2022
SELL
$543.48 - $670.97 $271,740 - $335,485
-500 Reduced 7.25%
6,400 $4.04 Million
Q3 2021

Oct 19, 2021
SELL
$574.03 - $680.96 $57,403 - $68,096
-100 Reduced 1.43%
6,900 $4.18 Million
Q2 2021

Jul 13, 2021
BUY
$472.8 - $558.54 $283,680 - $335,124
600 Added 9.38%
7,000 $3.91 Million
Q4 2020

Feb 02, 2021
SELL
$478.3 - $607.98 $47,830 - $60,798
-100 Reduced 1.54%
6,400 $3.09 Million
Q3 2020

Oct 28, 2020
BUY
$544.75 - $658.21 $217,900 - $263,284
400 Added 6.56%
6,500 $3.64 Million
Q3 2020

Oct 27, 2020
SELL
$544.75 - $658.21 $381,325 - $460,747
-700 Reduced 10.29%
6,100 $1.69 Million
Q2 2020

Aug 06, 2020
BUY
$493.32 - $643.92 $887,976 - $1.16 Million
1,800 Added 36.0%
6,800 $4.24 Million
Q1 2020

Jun 11, 2020
SELL
$336.18 - $494.43 $369,798 - $543,873
-1,100 Reduced 18.03%
5,000 $2.44 Million
Q3 2019

Nov 25, 2019
SELL
$273.46 - $318.39 $82,038 - $95,517
-300 Reduced 4.69%
6,100 $1.69 Million
Q2 2019

Aug 06, 2019
SELL
$299.6 - $414.82 $29,960 - $41,482
-100 Reduced 1.54%
6,400 $2 Million
Q1 2019

Apr 17, 2019
SELL
$372.08 - $439.57 $37,208 - $43,957
-100 Reduced 1.52%
6,500 $2.67 Million
Q4 2018

Jan 28, 2019
SELL
$335.82 - $403.04 $100,746 - $120,912
-300 Reduced 4.35%
6,600 $2.47 Million
Q3 2018

Nov 19, 2018
SELL
$351.14 - $408.51 $70,228 - $81,702
-200 Reduced 2.82%
6,900 $2.79 Million
Q2 2018

Aug 01, 2018
SELL
$284.6 - $344.99 $56,920 - $68,998
-200 Reduced 2.74%
7,100 $2.45 Million
Q1 2018

Apr 25, 2018
SELL
$315.82 - $393.78 $31,582 - $39,378
-100 Reduced 1.35%
7,300 $2.51 Million
Q4 2017

Feb 08, 2018
BUY
$358.63 - $469.95 $107,589 - $140,985
300 Added 4.23%
7,400 $2.78 Million
Q3 2017

Nov 21, 2017
BUY
$431.38 - $504.0 $3.06 Million - $3.58 Million
7,100
7,100 $3.18 Million

Others Institutions Holding REGN

# of Institutions
1,500
Shares Held
83M
Call Options Held
1.22M
Put Options Held
1.5M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track New Mexico Educational Retirement Board Portfolio

Follow New Mexico Educational Retirement Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Mexico Educational Retirement Board, based on Form 13F filings with the SEC.

News

Stay updated on New Mexico Educational Retirement Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email